Brainsway (BWAY) Competitors $15.32 +0.17 (+1.12%) As of 10:04 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BWAY vs. KMTS, ESTA, MDXG, INMD, TNDM, BBNX, IRMD, EMBC, CLPT, and AXGNShould you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include Kestra Medical Technologies (KMTS), Establishment Labs (ESTA), MiMedx Group (MDXG), InMode (INMD), Tandem Diabetes Care (TNDM), Beta Bionics (BBNX), iRadimed (IRMD), Embecta (EMBC), ClearPoint Neuro (CLPT), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. Brainsway vs. Its Competitors Kestra Medical Technologies Establishment Labs MiMedx Group InMode Tandem Diabetes Care Beta Bionics iRadimed Embecta ClearPoint Neuro AxoGen Brainsway (NASDAQ:BWAY) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment. Is BWAY or KMTS more profitable? Brainsway has a net margin of 11.60% compared to Kestra Medical Technologies' net margin of 0.00%. Brainsway's return on equity of 8.97% beat Kestra Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Brainsway11.60% 8.97% 5.65% Kestra Medical Technologies N/A N/A N/A Does the media prefer BWAY or KMTS? In the previous week, Brainsway had 1 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 5 mentions for Brainsway and 4 mentions for Kestra Medical Technologies. Brainsway's average media sentiment score of 0.63 beat Kestra Medical Technologies' score of 0.55 indicating that Brainsway is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brainsway 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in BWAY or KMTS? 30.1% of Brainsway shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings and valuation, BWAY or KMTS? Brainsway has higher earnings, but lower revenue than Kestra Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainsway$41.02M7.10$2.92M$0.2658.92Kestra Medical Technologies$66.40M17.86-$113.81MN/AN/A Do analysts rate BWAY or KMTS? Brainsway presently has a consensus price target of $18.00, indicating a potential upside of 17.49%. Kestra Medical Technologies has a consensus price target of $27.33, indicating a potential upside of 18.58%. Given Kestra Medical Technologies' higher possible upside, analysts plainly believe Kestra Medical Technologies is more favorable than Brainsway.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Brainsway 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Kestra Medical Technologies 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57 SummaryBrainsway beats Kestra Medical Technologies on 9 of the 13 factors compared between the two stocks. Get Brainsway News Delivered to You Automatically Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BWAY vs. The Competition Export to ExcelMetricBrainswayMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$291.08M$10.45B$6.04B$10.53BDividend YieldN/A1.89%5.73%4.80%P/E Ratio58.9321.1084.5127.54Price / Sales7.1036.60513.90198.23Price / Cash60.8025.0637.5761.53Price / Book4.633.4812.286.84Net Income$2.92M$210.63M$3.32B$276.59M7 Day Performance-1.29%-0.12%-0.30%0.64%1 Month Performance1.46%3.71%9.36%8.73%1 Year Performance64.38%-3.84%72.91%35.73% Brainsway Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BWAYBrainsway3.3953 of 5 stars$15.32+1.1%$18.00+17.5%+61.3%$291.08M$41.02M58.93120News CoverageAnalyst ForecastKMTSKestra Medical Technologies1.3635 of 5 stars$22.58+2.6%$27.33+21.1%N/A$1.13B$59.81M0.00300Gap UpESTAEstablishment Labs2.5599 of 5 stars$41.16+5.7%$56.50+37.3%+7.6%$1.13B$166.02M-13.501,018News CoverageMDXGMiMedx Group3.4285 of 5 stars$6.51-0.6%$12.00+84.3%+14.8%$969.13M$348.88M31.00870News CoverageINMDInMode2.674 of 5 stars$15.30+0.2%$18.21+19.0%-7.3%$964.89M$394.82M6.19480TNDMTandem Diabetes Care4.2191 of 5 stars$13.87-0.9%$22.69+63.6%-61.5%$945.97M$940.20M-4.492,650BBNXBeta Bionics1.7732 of 5 stars$22.15+5.3%$24.44+10.4%N/A$914.18M$65.12M0.00294IRMDiRadimed4.5743 of 5 stars$72.41+1.0%$72.00-0.6%+45.4%$911.42M$73.24M44.70110News CoverageInsider TradeEMBCEmbecta4.6013 of 5 stars$13.35-0.2%$19.00+42.3%+3.4%$782.53M$1.12B9.342,100CLPTClearPoint Neuro0.8342 of 5 stars$26.27+0.6%$19.67-25.1%+109.8%$742.24M$31.39M-32.43110Insider TradeGap UpAXGNAxoGen3.0468 of 5 stars$15.59-2.5%$25.75+65.2%+11.4%$735.74M$187.34M-155.88450 Related Companies and Tools Related Companies KMTS Alternatives ESTA Alternatives MDXG Alternatives INMD Alternatives TNDM Alternatives BBNX Alternatives IRMD Alternatives EMBC Alternatives CLPT Alternatives AXGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BWAY) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainsway Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainsway With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
